Synthesis and anti-retroviral activity of O,O'-bis(3'-azido-2',3'-dideoxythymidin-5'-yl) phosphoramidate derivatives. 1999

I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
Department of Organic Chemistry, Arrhenius Laboratory, Stockholm University, Sweden.

A simple and efficient protocol for the preparation of various symmetrical dinucleoside phosphoramidates derived from AZT, is presented. It consists of the phosphonylation of AZT with phosphonic acid in the presence of DCC to produce the symmetrical H-phosphonate diester, followed by its oxidative conversion to various phosphoramidate analogues. The synthesized compounds were evaluated for their anti-HIV activity in different cell cultures.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010756 Phosphoric Acids Inorganic derivatives of phosphoric acid (H3PO4). Note that organic derivatives of phosphoric acids are listed under ORGANOPHOSPHATES. Pyrophosphoric Acids,Acids, Phosphoric,Acids, Pyrophosphoric
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
January 1999, Nucleosides & nucleotides,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
March 2001, Journal of medicinal chemistry,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
July 1993, Archiv der Pharmazie,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
January 1991, Antiviral research,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
January 1999, Nucleosides & nucleotides,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
July 2007, Bioorganic & medicinal chemistry letters,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
October 2000, Archiv der Pharmazie,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
December 2001, The Journal of organic chemistry,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
September 1990, Journal of medicinal chemistry,
I Kers, and J Stawiński, and J L Girardet, and J L Imbach, and C Périgaud, and G Gosselin, and A M Aubertin
August 2001, Journal of medicinal chemistry,
Copied contents to your clipboard!